# Preventing Respiratory Viral Illness Invisibly

> **NCT05084898** · NA · COMPLETED · sponsor: **Kenneth Rockwood** · enrollment: 550 (actual)

## Conditions studied

- COVID-19 Respiratory Infection
- Respiratory Virus Infection
- Influenza -Like Illness

## Interventions

- **OTHER:** Far-UVC light as an additional method of disinfection
- **OTHER:** Placebo fluorescent light

## Key facts

- **NCT ID:** NCT05084898
- **Lead sponsor:** Kenneth Rockwood
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084898, "Preventing Respiratory Viral Illness Invisibly". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05084898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*